Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...

Patients with axial spondyloarthritis and psoriatic arthritis face an elevated risk for all-cause mortality compared with the ...

I’ve seen a big increase in our understanding of psoriatic arthritis just in my time in practice. This has resulted in more specific treatments but also our ability to make a more rapid diagnosis.

Bristol Myers BMY recently secured a meaningful label expansion for Sotyktu, with the FDA approving the drug for adults with ...

Oral TYK2 inhibitor deucravacitinib receives FDA approval for active psoriatic arthritis based on significantly improved ...

Psoriatic arthritis (PsA) causes your immune system to attack your joints, but it can also affect many other parts of your body. PsA usually comes alongside psoriasis, a similar long-term, ...

In phase 3 clinical trials, tildrakizumab treatment was associated with significantly higher ACR20 response rates at week 24 compared with placebo.

When you have psoriatic arthritis, following the treatment plan as prescribed is crucial for slowing the progression of the disease and easing symptoms. Adding complementary therapies to the overall ...

Ilumya has secured marketing authorisations from more than 55 health authorities worldwide.

Psoriatic arthritis is a chronic inflammatory condition that can significantly impact the quality of life of those affected. Understanding where and how this disease manifests in the body can help in ...

Add Yahoo as a preferred source to see more of our stories on Google. Dealing with the itchy, scaly patches that come with psoriasis is difficult enough. But having psoriasis puts you at risk of ...

Joni Kazantzis was diagnosed with psoriasis at 15 and received a psoriatic arthritis diagnosis during the pandemic. She created a blog and social platform to offer the guidance she once ...